These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 25895909

  • 1. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
    Okamoto Y, Okubo K, Yonekura S, Hashiguchi K, Goto M, Otsuka T, Murata T, Nakao Y, Kanazawa C, Nagakura H, Okawa T, Nakano K, Hisamitsu M, Kaneko S, Konno A.
    Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
    [Abstract] [Full Text] [Related]

  • 2. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
    Gotoh M, Yonekura S, Imai T, Kaneko S, Horikawa E, Konno A, Okamoto Y, Okubo K.
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1287-1297.e8. PubMed ID: 30537561
    [Abstract] [Full Text] [Related]

  • 3. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
    Mitobe Y, Yokomoto Y, Ohashi-Doi K.
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
    [Abstract] [Full Text] [Related]

  • 4. A randomized double-blind comparative study of sublingual immunotherapy for cedar pollinosis.
    Okubo K, Gotoh M, Fujieda S, Okano M, Yoshida H, Morikawa H, Masuyama K, Okamoto Y, Kobayashi M.
    Allergol Int; 2008 Sep; 57(3):265-75. PubMed ID: 18566549
    [Abstract] [Full Text] [Related]

  • 5. Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons.
    Yonekura S, Gotoh M, Kaneko S, Kanazawa K, Takeuji Y, Okubo K, Okamoto Y.
    Allergol Int; 2019 Oct; 68(4):494-505. PubMed ID: 31257168
    [Abstract] [Full Text] [Related]

  • 6. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T.
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.
    Ott H, Sieber J, Brehler R, Fölster-Holst R, Kapp A, Klimek L, Pfaar O, Merk H.
    Allergy; 2009 Sep; 64(9):1394-401. PubMed ID: 19764942
    [Abstract] [Full Text] [Related]

  • 8. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE THIRD TREATED YEAR WITH JAPANESE CEDAR POLLINOSIS IN 2017].
    Yuta A, Ogawa Y, Suzuki Y, Ogihara H, Ohta N, Kozaki H, Shimizu T.
    Arerugi; 2017 Sep; 66(9):1172-1180. PubMed ID: 29129888
    [Abstract] [Full Text] [Related]

  • 9. Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
    Fujii T, Kitamura Y, Kamimura S, Naito K, Takeda N.
    Auris Nasus Larynx; 2021 Aug; 48(4):653-658. PubMed ID: 33461852
    [Abstract] [Full Text] [Related]

  • 10. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis.
    Hamada S, Kobayashi Y, Sakamoto D, Shimamura A, Kuroda K, Kawachi R, Kanda A, Asako M, Gotoh M, Okubo K, Tomoda K, Iwai H.
    Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319
    [Abstract] [Full Text] [Related]

  • 11. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study.
    Murakami D, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S.
    Auris Nasus Larynx; 2016 Feb; 43(1):50-5. PubMed ID: 26197940
    [Abstract] [Full Text] [Related]

  • 12. Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets.
    Yonekura S, Gotoh M, Kaneko S, Maekawa Y, Okubo K, Okamoto Y.
    J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4103-4116.e14. PubMed ID: 34333190
    [Abstract] [Full Text] [Related]

  • 13. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
    Sakurai T, Yonekura S, Iinuma T, Sakurai D, Morimoto Y, Kaneko S, Okamoto Y.
    Int Arch Allergy Immunol; 2018 Nov; 177(3):245-254. PubMed ID: 30021201
    [Abstract] [Full Text] [Related]

  • 14. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
    Yamanaka K, Shah SA, Sakaida H, Yamagiwa A, Masuda S, Mizutani H, Takeuchi K.
    Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
    [Abstract] [Full Text] [Related]

  • 15. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
    Yuta A, Miyamoto Y, Ogihara H, Hattori R, Okubo K.
    Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
    [Abstract] [Full Text] [Related]

  • 16. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial.
    Nomura Y, Okubo K, Nakamura T, Sawaki S, Kitagou H, Idei N, Kaneko S, Kobayashi S, Tanaka Y, Okamoto Y.
    Allergol Int; 2021 Jan; 70(1):96-104. PubMed ID: 32653209
    [Abstract] [Full Text] [Related]

  • 17. An analysis of factors related to the effect of sublingual immunotherapy on Japanese cedar pollen induced allergic rhinitis.
    Yonekura S, Okamoto Y, Sakurai D, Okubo K, Gotoh M, Kaneko S, Konno A.
    Allergol Int; 2018 Apr; 67(2):201-208. PubMed ID: 28760534
    [Abstract] [Full Text] [Related]

  • 18. [Adherence and Clinical Outcome of Sublingual Immunotherapy for Japanese Cedar Pollinosis].
    Yuta A, Ogawa Y, Suzuki Y, Arikata M, Kozaki H, Shimizu T, Ohta N.
    Nihon Jibiinkoka Gakkai Kaiho; 2016 Dec; 119(12):1504-10. PubMed ID: 30035481
    [Abstract] [Full Text] [Related]

  • 19. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Yamamoto H, Kunii N, Sakurai D, Fujimura T, Nakazawa K, Yasueda H.
    Int Arch Allergy Immunol; 2008 Dec; 146(1):76-84. PubMed ID: 18087165
    [Abstract] [Full Text] [Related]

  • 20. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K, Gotoh M.
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.